Eyenovia to Present at the 22nd Annual H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company, will present at the 22nd Annual H.C. Wainwright Global Investment Conference from September 14-16, 2020. The presentation will be delivered by Dr. Sean Ianchulev, CEO, and John Gandolfo, CFO, on September 15, 2020, from 2:30 to 2:50 PM ET. Eyenovia focuses on developing microdose array print (MAP™) therapeutics targeting presbyopia, myopia progression, and mydriasis. For more details, visit www.eyenovia.com.

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that Dr. Sean Ianchulev, Eyenovia’s Chief Executive Officer and Chief Medical Officer and John Gandolfo, Eyenovia’s Chief Financial Officer, are scheduled to present at the 22^nd Annual H.C. Wainwright Global Investment Conference being held virtually on September 14-16, 2020.

Details of the presentation are below:

Event: 22^nd Annual H.C. Wainwright Global Investment Conference
Date: Tuesday, September 15, 2020
Presentation Time: 2:30-2:50 PM ET

About Eyenovia, Inc.

Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more Information, please visit www.eyenovia.com.

Company Contact:
Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
jgandolfo@eyenovia.com

Investor Contact:
The Ruth Group
Carol Ruth
Phone: 646-536-7004
cruth@theruthgroup.com

 

FAQ

When is Eyenovia's presentation at the H.C. Wainwright Global Investment Conference?

Eyenovia will present on September 15, 2020, from 2:30 to 2:50 PM ET.

Who will present for Eyenovia at the conference?

Dr. Sean Ianchulev and John Gandolfo will present for Eyenovia.

What is Eyenovia's focus in their pipeline?

Eyenovia focuses on developing microdosed medications for presbyopia, myopia progression, and mydriasis.

What are the dates of the 22nd Annual H.C. Wainwright Global Investment Conference?

The conference will be held virtually from September 14-16, 2020.

What is the stock symbol for Eyenovia?

The stock symbol for Eyenovia is EYEN.